{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T02:27:43Z","timestamp":1776479263304,"version":"3.51.2"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,3,18]],"date-time":"2013-03-18T00:00:00Z","timestamp":1363564800000},"content-version":"vor","delay-in-days":76,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics"],"published-print":{"date-parts":[[2013]]},"DOI":"10.6061\/clinics\/2013(02)rc01","type":"journal-article","created":{"date-parts":[[2013,3,4]],"date-time":"2013-03-04T15:23:56Z","timestamp":1362410636000},"page":"277-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype"],"prefix":"10.1016","volume":"68","author":[{"given":"Giselle","family":"Izzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orestes V.","family":"Forlenza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernardo","family":"dos Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo H.F.","family":"Bertolucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elida B.","family":"Ojopi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner F.","family":"Gattaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Shikanai","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5646","key":"10.6061\/clinics\/2013(02)RC01_bib1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1126\/science.1092132","article-title":"The genetics of adult-onset neuropsychiatric disease: complexities and conundra?","volume":"302","author":"Kennedy","year":"2003","journal-title":"Science"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/archpsyc.63.2.168","article-title":"Role of genes and environments for explaining Alzheimer disease","volume":"63","author":"Gatz","year":"2006","journal-title":"Archives of general psychiatry"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000104467","article-title":"Cognitive impairment in Alzheimer's disease is modified by APOE genotype","volume":"24","author":"van der Vlies","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.6061\/clinics\/2013(02)RC01_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1590\/S0004-282X1997000100001","article-title":"Apolipoprotein E4 and Alzheimer's disease in Sao Paulo-Brazil","volume":"55","author":"Almeida","year":"1997","journal-title":"Arquivos de neuro-psiquiatria"},{"issue":"10","key":"10.6061\/clinics\/2013(02)RC01_bib5","first-page":"93","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"issue":"10","key":"10.6061\/clinics\/2013(02)RC01_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"issue":"17","key":"10.6061\/clinics\/2013(02)RC01_bib7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1097\/WNR.0b013e3282f13e7a","article-title":"Association between SORL1 and Alzheimer's disease in a genome-wide study","volume":"18","author":"Meng","year":"2007","journal-title":"Neuroreport"},{"issue":"26","key":"10.6061\/clinics\/2013(02)RC01_bib8","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1056\/NEJMp0804318","article-title":"From Darwin's finches to canaries in the coal mine\u2013mining the genome for new biology","volume":"358","author":"Hunter","year":"2008","journal-title":"N Engl J Med"},{"issue":"7215","key":"10.6061\/clinics\/2013(02)RC01_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nature07454","article-title":"A glimmer of light for neuropsychiatric disorders","volume":"455","author":"Hyman","year":"2008","journal-title":"Nature"},{"issue":"5","key":"10.6061\/clinics\/2013(02)RC01_bib10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/humu.20725","article-title":"SORL1 is genetically associated with increased risk for late-onset Alzheimer disease in the Belgian population","volume":"29","author":"Bettens","year":"2008","journal-title":"Hum Mutat"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.neulet.2008.05.082","article-title":"No association of SORL1 SNPs with Alzheimer's disease","volume":"440","author":"Minster","year":"2008","journal-title":"Neurosci Lett"},{"issue":"10","key":"10.6061\/clinics\/2013(02)RC01_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1001\/archneurol.2009.101","article-title":"Implication of sex and SORL1 variants in italian patients with Alzheimer disease","volume":"66","author":"Cellini","year":"2009","journal-title":"Arch Neurol"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib13","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/ng1943","article-title":"The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease","volume":"39","author":"Rogaeva","year":"2007","journal-title":"Nat Genet"},{"issue":"7","key":"10.6061\/clinics\/2013(02)RC01_bib14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuint.2012.07.014","article-title":"SORL1 and SIRT1 mRNA expression and promoter methylation levels in aging and Alzheimer's Disease","volume":"61","author":"Furuya","year":"2012","journal-title":"Neurochem Int"},{"issue":"5","key":"10.6061\/clinics\/2013(02)RC01_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neuron.2007.05.022","article-title":"GAB2 alleles modify Alzheimer's risk in APOE epsilon4 carriers","volume":"54","author":"Reiman","year":"2007","journal-title":"Neuron"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib16","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/humu.20909","article-title":"Common variation in GRB-associated Binding Protein 2 (GAB2) and increased risk for Alzheimer dementia","volume":"30","author":"Sleegers","year":"2009","journal-title":"Hum Mutat"},{"issue":"1","key":"10.6061\/clinics\/2013(02)RC01_bib17","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.nbd.2007.12.006","article-title":"Association study of the GAB2 gene with the risk of developing Alzheimer's disease","volume":"30","author":"Chapuis","year":"2008","journal-title":"Neurobiol Dis"},{"issue":"3","key":"10.6061\/clinics\/2013(02)RC01_bib18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10072-009-0178-8","article-title":"GAB2 is not associated with late-onset Alzheimer's disease in Chinese Han","volume":"31","author":"Lin","year":"2010","journal-title":"Neurol Sci"},{"key":"10.6061\/clinics\/2013(02)RC01_bib19","first-page":"9","article-title":"Common variant in GAB2 is associated with late-onset Alzheimer's disease in Han Chinese","volume":"412(5-6)","author":"Zhong","year":"2011","journal-title":"Clin Chim Acta"},{"issue":"4","key":"10.6061\/clinics\/2013(02)RC01_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.21476","article-title":"Glycogen synthase kinase-3beta and tau genes interact in Alzheimer's disease","volume":"64","author":"Kwok","year":"2008","journal-title":"Ann Neurol"},{"issue":"7","key":"10.6061\/clinics\/2013(02)RC01_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"3","key":"10.6061\/clinics\/2013(02)RC01_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1590\/S1516-44462010005000002","article-title":"Clinical and biological predictors of Alzheimer's disease in patients with amnestic mild cognitive impairment","volume":"32","author":"Forlenza","year":"2010","journal-title":"Rev Bras Psiquiatr"},{"issue":"8","key":"10.6061\/clinics\/2013(02)RC01_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"issue":"5","key":"10.6061\/clinics\/2013(02)RC01_bib24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.6061\/clinics\/2013(02)RC01_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1176\/ajp.2007.164.6.916","article-title":"Correlations between apolipoprotein E epsilon4 gene dose and whole brain atrophy rates","volume":"164","author":"Chen","year":"2007","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.6061\/clinics\/2013(02)RC01_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S0100-879X2003000700013","article-title":"Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians","volume":"36","author":"Souza","year":"2003","journal-title":"Braz J Med Biol Res"},{"issue":"1","key":"10.6061\/clinics\/2013(02)RC01_bib27","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1097\/WAD.0b013e31815a9da7","article-title":"Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease","volume":"22","author":"Bahia","year":"2008","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"6","key":"10.6061\/clinics\/2013(02)RC01_bib28","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ana.20691","article-title":"GSK3B polymorphisms alter transcription and splicing in Parkinson's disease","volume":"58","author":"Kwok","year":"2005","journal-title":"Ann Neurol"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1385\/NMM:2:2:151","article-title":"Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease","volume":"2","author":"Terwel","year":"2002","journal-title":"Neuromolecular Med"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.18388\/abp.2004_3582","article-title":"Targeting BACE with small inhibitory nucleic acids - a future for Alzheimer's disease therapy?","volume":"51","author":"Nawrot","year":"2004","journal-title":"Acta Biochim Pol"},{"key":"10.6061\/clinics\/2013(02)RC01_bib31","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.2002.tb04660.x","article-title":"Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc\/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain","volume":"973","author":"Russo","year":"2002","journal-title":"Ann N Y Acad Sci"},{"issue":"18","key":"10.6061\/clinics\/2013(02)RC01_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1074\/jbc.M610146200","article-title":"Amyloid precursor protein and Presenilin1 interact with the adaptor GRB2 and modulate ERK 1,2 signaling","volume":"282","author":"Nizzari","year":"2007","journal-title":"J Biol Chem"},{"issue":"13","key":"10.6061\/clinics\/2013(02)RC01_bib33","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/sj.emboj.7600251","article-title":"PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations","volume":"23","author":"Baki","year":"2004","journal-title":"EMBO J"},{"issue":"2","key":"10.6061\/clinics\/2013(02)RC01_bib34","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2009.09.011","article-title":"GSK3: a possible link between beta amyloid peptide and tau protein","volume":"223","author":"Hern\u00e1ndez","year":"2010","journal-title":"Exp Neurol"}],"container-title":["Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222021147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1807593222021147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/clinics.org.br\/uploads\/artigos\/cln-68-02\/cln-68-02-277.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T07:09:54Z","timestamp":1761721794000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1807593222021147"},"secondary":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_abstract&pid=S1807-59322013000200025&lng=en&nrm=iso&tlng=en","label":"SCIELO"},{"URL":"http:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3584260\/?report=classic","label":"PMC"}]},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013]]}},"alternative-id":["S1807593222021147"],"URL":"https:\/\/doi.org\/10.6061\/clinics\/2013(02)rc01","relation":{},"ISSN":["1807-5932"],"issn-type":[{"value":"1807-5932","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Single-nucleotide polymorphisms of GSK3B, GAB2 and SORL1 in late-onset Alzheimer's disease: interactions with the APOE genotype","name":"articletitle","label":"Article Title"},{"value":"Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.6061\/clinics\/2013(02)RC01","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 CLINICS. Published by Elsevier Spain","name":"copyright","label":"Copyright"}]}}